Unknown

Dataset Information

0

Hemorrhoids.

ABSTRACT: Hemorrhoid disease is the most common reason patients seek evaluation by a colon and rectal surgeon. The majority of hemorrhoids can be managed nonoperatively with medical management or office-based procedures. The authors review the anatomy, pathophysiology, presentation, and management of hemorrhoids.

SUBMITTER: Sanchez C 

PROVIDER: S-EPMC3140328 | biostudies-other | 2011 Mar

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with Vemurafenib in combination with chromatin-targeting compounds (immunofluorescence dataset 3 of 4)
2017-01-20 | LDS-1370 | LINCS
Unknown LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 8 of 9: Calculated dose-response metrics for biological replicate 2
2017-03-14 | LDS-1380 | LINCS
Unknown MEMA HMEC240L Staining Set 4
2016-11-10 | LDS-1439 | LINCS
Unknown GCP aggregated data - CRISPR perturbations
2017-10-20 | LDS-1498 | LINCS
Unknown MGH (CMT) Growth Inhibition Assay Protocol (9 compound doses: 8 uM to 0.03125 uM) -- DNA Staining
2014-05-30 | EDS-1003 | LINCS
Unknown MGH (CMT) Growth Inhibition Assay Protocol (9 compound doses: 5.12 uM to 0.02 uM) -- DNA Staining
2014-05-30 | EDS-1004 | LINCS
Unknown Tang Proliferation/Mitosis
2015-09-25 | LDS-1005 | LINCS
Unknown Growth factor-induced ERK activity and FoxO3a nuclear-cytoplasmic pulsing dynamics in a mammary epithelial cell line. Dataset 1 of 1: single-cell reporter measurements.
2017-05-02 | LDS-1394 | LINCS
Unknown LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates.
2017-03-14 | LDS-1232 | LINCS
Unknown Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics.
2017-03-14 | LDS-1363 | LINCS